Dthera Sciences (DTHR) Financial Statements (2025 and earlier)

Company Profile

Business Address 9921 CARMEL MOUNTAIN ROAD, SUITE 118
SAN DIEGO, CA 92129
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 738 - Miscellaneous Business Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments70429323150179467
Cash and cash equivalent70429323150179467
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Prepaid expense6302789510  
Deposits current assets333111
Other undisclosed current assets20     
Total current assets:723709421161180468
Noncurrent Assets
Property, plant and equipment89937750501
Other undisclosed noncurrent assets18679    
Total noncurrent assets:2751727750501
TOTAL ASSETS:999881499211230469
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:529312429220168244
Other undisclosed accounts payable and accrued liabilities529312429220168244
Debt100    70
Derivative instruments and hedges, liabilities      
Deferred revenue and credits21  
Due to related parties  1677 4
Other undisclosed current liabilities43    
Total current liabilities:633331438227168318
Noncurrent Liabilities
Total liabilities:633331438227168318
Equity
Equity, attributable to parent36655060(16)62152
Common stock515047451441
Common stock, share subscribed but unissued, subscriptions receivable      (10)
Additional paid in capital6,3576,1474,5503,9833,8352,585
Accumulated deficit(6,042)(5,147)(4,537)(4,044)(3,787)(2,465)
Stockholders' equity note, subscriptions receivable  (500)    
Other undisclosed equity    000
Total equity:36655060(16)62152
TOTAL LIABILITIES AND EQUITY:999881499211230469

Income Statement (P&L) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues      
Cost of revenue      
Other cost of operating revenue      
Gross profit:      
Operating expenses(889)(607)(493)(257)(1,321)(352)
Operating loss:(889)(607)(493)(257)(1,321)(352)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(5)(3)0  (135)
Interest and debt expense(2)(0)   (92)
Loss from continuing operations:(896)(611)(493)(257)(1,321)(579)
Loss before gain (loss) on sale of properties:(896)(611)(493)(257)(1,321)(579)
Net loss:(896)(611)(493)(257)(1,321)(579)
Other undisclosed net income attributable to parent20   92
Net loss available to common stockholders, diluted:(894)(611)(493)(257)(1,321)(487)

Comprehensive Income ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net loss:(896)(611)(493)(257)(1,321)(579)
Comprehensive loss, net of tax, attributable to parent:(896)(611)(493)(257)(1,321)(579)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: